Article ID Journal Published Year Pages File Type
2581974 Chemico-Biological Interactions 2008 8 Pages PDF
Abstract
We propose that the strategy of PSA-based early phase II clinical trials accompanied by experimental human xenograft studies, to assess the reliability of PSA response to reflect tumor response, allows for a concise, relatively fast test system that is able to screen the various treatment options for chemoprevention in a relatively short period of time.
Related Topics
Life Sciences Environmental Science Health, Toxicology and Mutagenesis
Authors
, ,